August 30, 2016 7:04 PM ET


Company Overview of KeraCure, Inc.

Executive Profile

Peter Courossi MBA

Director, KeraCure, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 6 different industries.

See Board Relationships


Mr. Peter Courossi, MBA served as Chief Financial Officer of Civitas Therapeutics, Inc. Mr. Courossi served as Chief Financial Officer of Visterra, Inc. since September 2010. He served as Chief Financial Officer of Acceleron Pharma, Inc. since October 2006. Mr. Courossi served as Chief Financial Officer of Alinea Pharmaceuticals, Inc. Mr. Courossi served as Interim Chief Financial Officer of Sention, Inc. and AVEO Pharmaceuticals, Inc. He is a financial executive with ...

Corporate Headquarters

101 North Wacker Drive
Chicago, Illinois 60606

United States

Phone: 312-587-1078
Fax: 312-780-7588

Board Members Memberships



Babson College

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact KeraCure, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at